Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Cash from Operations (2016 - 2026)

Viking Therapeutics (VKTX) has disclosed Cash from Operations for 13 consecutive years, with 113976000.0 as the latest value for Q1 2026.

  • For Q1 2026, Cash from Operations fell 117.8% year-over-year to 113976000.0; the TTM value through Mar 2026 reached 340330000.0, down 154.0%, while the annual FY2025 figure was 278685000.0, 217.45% down from the prior year.
  • Cash from Operations hit 113976000.0 in Q1 2026 for Viking Therapeutics, down from 85290000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 6134000.0 in Q1 2024 and bottomed at 113976000.0 in Q1 2026.
  • Average Cash from Operations over 5 years is 35424941.18, with a median of 21962000.0 recorded in 2024.
  • Year-over-year, Cash from Operations skyrocketed 75.11% in 2024 and then tumbled 753.13% in 2025.
  • Viking Therapeutics' Cash from Operations stood at 10926000.0 in 2022, then tumbled by 61.45% to 17640000.0 in 2023, then crashed by 76.76% to 31181000.0 in 2024, then crashed by 173.53% to 85290000.0 in 2025, then tumbled by 33.63% to 113976000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 113976000.0, 85290000.0, and 94003000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.